Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brehm

Showing results (141-150 of 292) with videos related to

Pageof 30
Sort By:
Journal of Immunological Methods|April 10, 2017
A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivoMohit K Verma, Julia Clemens, Lisa Burzenski, et al.
Seminars in Perioperative Nursing|May 8, 2004
Evidence for opioid variability, Part 1: A biological perspectiveR C Polomano, C M Gelnett, S M Heffner, et al.
Insect Molecular Biology|March 21, 2002
Structure and evolution of the mitochondrial DNA complete control region in the Drosophila subobscura subgroupA Brehm, D J Harris, M Hernández, et al.
Stem Cell Research|October 14, 2014
Extensive double humanization of both liver and hematopoiesis in FRGN miceElizabeth M Wilson, J Bial, Branden Tarlow, et al.
Cellular Signalling|August 26, 2011
The inositol 5-phosphatase SHIP1 is a nucleo-cytoplasmic shuttling protein and enzymatically active in cell nucleiMarcus M Nalaskowski, Anja Metzner, Maria A Brehm, et al.
The EMBO Journal|May 6, 1999
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growthA Brehm, S J Nielsen, E A Miska, et al.
Development (Cambridge, England)|March 1, 1996
Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cellsY I Yeom, G Fuhrmann, C E Ovitt, et al.
Plos One|January 31, 2018
Correction: Aerobic Exercise Training in Post-Polio Syndrome: Process Evaluation of a Randomized Controlled TrialEric L Voorn, Fieke S Koopman, Merel A Brehm, et al.
Diabetes, Obesity & Metabolism|April 12, 2013
Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetesE Phielix, A Brehm, E Bernroider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Partial versus full allogeneic hemopoietic chimerization is a preferential means to inhibit type 1 diabetes as the latter induces generalized immunosuppressionDavid V Serreze, Melissa A Osborne, Yi-Guang Chen, et al.
Pageof 30

Showing results (141-150 of 292) with videos related to

Sort By:
Pageof 30
Journal of Immunological Methods|April 10, 2017
A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivoMohit K Verma, Julia Clemens, Lisa Burzenski, et al.
Seminars in Perioperative Nursing|May 8, 2004
Evidence for opioid variability, Part 1: A biological perspectiveR C Polomano, C M Gelnett, S M Heffner, et al.
Insect Molecular Biology|March 21, 2002
Structure and evolution of the mitochondrial DNA complete control region in the Drosophila subobscura subgroupA Brehm, D J Harris, M Hernández, et al.
Stem Cell Research|October 14, 2014
Extensive double humanization of both liver and hematopoiesis in FRGN miceElizabeth M Wilson, J Bial, Branden Tarlow, et al.
Cellular Signalling|August 26, 2011
The inositol 5-phosphatase SHIP1 is a nucleo-cytoplasmic shuttling protein and enzymatically active in cell nucleiMarcus M Nalaskowski, Anja Metzner, Maria A Brehm, et al.
The EMBO Journal|May 6, 1999
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growthA Brehm, S J Nielsen, E A Miska, et al.
Development (Cambridge, England)|March 1, 1996
Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cellsY I Yeom, G Fuhrmann, C E Ovitt, et al.
Plos One|January 31, 2018
Correction: Aerobic Exercise Training in Post-Polio Syndrome: Process Evaluation of a Randomized Controlled TrialEric L Voorn, Fieke S Koopman, Merel A Brehm, et al.
Diabetes, Obesity & Metabolism|April 12, 2013
Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetesE Phielix, A Brehm, E Bernroider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Partial versus full allogeneic hemopoietic chimerization is a preferential means to inhibit type 1 diabetes as the latter induces generalized immunosuppressionDavid V Serreze, Melissa A Osborne, Yi-Guang Chen, et al.
Pageof 30